Use Actual Body Weight When Calculating Renal Function For Edoxaban
Savaysa (sa-VAYE-sah, edoxaban) will be the fourth new oral anticoagulant (NOAC)...after Pradaxa, Xarelto, and Eliquis.
It's approved for once-daily use in atrial fib and venous thromboembolism (VTE).
But edoxaban has an odd twist when used for A fib. It does NOT work as well as warfarin in patients with NORMAL kidney function.